-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Underperform on ImageneBio, Maintains $2 Price Target

Benzinga·05/11/2026 12:31:33
Listen to the news
Wedbush analyst Martin Fan reiterates ImageneBio (NASDAQ:IMA) with a Underperform and maintains $2 price target.